STOCK TITAN

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Co-Diagnostics (NASDAQ: CODX) announced it will release its third quarter 2024 financial results on Thursday, November 7, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. ET the same day, featuring CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. The event will be accessible via webcast on the company's investor relations website and through conference call lines. A recording will be available later on the company's website for those unable to attend live.

Co-Diagnostics (NASDAQ: CODX) ha annunciato che rilascerà i risultati finanziari del terzo trimestre 2024 giovedì 7 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET dello stesso giorno, con l'amministratore delegato Dwight Egan, il CFO Brian Brown e il responsabile delle relazioni con gli investitori Andrew Benson. L'evento sarà accessibile tramite webcast sul sito web delle relazioni con gli investitori dell'azienda e attraverso le linee della conferenza telefonica. Una registrazione sarà disponibile successivamente sul sito web dell'azienda per coloro che non potranno partecipare dal vivo.

Co-Diagnostics (NASDAQ: CODX) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el jueves 7 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada telefónica y un webcast a las 4:30 p.m. ET el mismo día, con el CEO Dwight Egan, el CFO Brian Brown y el Jefe de Relaciones con Inversores Andrew Benson. El evento será accesible a través de webcast en el sitio web de relaciones con inversores de la empresa y a través de líneas de conferencia telefónica. Una grabación estará disponible más tarde en el sitio web de la empresa para aquellos que no puedan asistir en vivo.

코다이AGNostics (NASDAQ: CODX)는 2024년 11월 7일 목요일 시장 종료 후 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 CEO 드와이트 에건, CFO 브라이언 브라운 및 투자자 관계 책임자 앤드류 벤슨이 참여하는 콘퍼런스 콜 및 웹캐스트를 개최합니다. 이 행사는 회사의 투자자 관계 웹사이트와 컨퍼런스 콜을 통해 접근할 수 있습니다. 실시간으로 참석할 수 없는 분들은 나중에 회사 웹사이트에서 녹화를 이용할 수 있습니다.

Co-Diagnostics (NASDAQ: CODX) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le jeudi 7 novembre 2024, après la fermeture des marchés. L'entreprise organisera une conférence téléphonique et un webcast à 16h30 ET le même jour, avec le PDG Dwight Egan, le directeur financier Brian Brown et le responsable des relations avec les investisseurs Andrew Benson. L'événement sera accessible par webcast sur le site des relations investisseurs de l'entreprise et via des lignes de conférence téléphonique. Un enregistrement sera disponible plus tard sur le site de l'entreprise pour ceux qui ne pourront pas assister en direct.

Co-Diagnostics (NASDAQ: CODX) gab bekannt, dass die Finanzergebnisse für das dritte Quartal 2024 am Donnerstag, den 7. November 2024, nach Börsenschluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, bei der CEO Dwight Egan, CFO Brian Brown und der Leiter der Investor Relations Andrew Benson teilnehmen werden. Die Veranstaltung wird über den Webcast auf der Investor Relations-Website des Unternehmens und über Telefonkonferenzleitungen zugänglich sein. Eine Aufnahme wird später auf der Website des Unternehmens für diejenigen verfügbar sein, die nicht live teilnehmen können.

Positive
  • None.
Negative
  • None.

SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.codiagnostics.com on the Events & Webcasts page

Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-third-quarter-2024-earnings-release-date-and-webcast-302287677.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics (CODX) release Q3 2024 earnings?

Co-Diagnostics will release its Q3 2024 earnings on Thursday, November 7, 2024, after the market close.

What time is Co-Diagnostics (CODX) Q3 2024 earnings call?

The earnings conference call and webcast will be held at 4:30 p.m. ET on Thursday, November 7, 2024.

How can I access Co-Diagnostics (CODX) Q3 2024 earnings call?

The earnings call can be accessed via webcast at ir.codiagnostics.com or by phone at 844-481-2661 (domestic) or 412-317-0652 (international).

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

33.21M
30.21M
5.4%
14.01%
0.65%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY